Search
for
Sort by
Research 421–450 of 1000+
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- Update on Efficacy of Generic Finasteride
- Exploring novel management options for alopecia areata
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- A pharmacovigilance study of drug‐reduced male semen quality based on the Food and Drug Administration adverse event reporting system database
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN
- Bimatoprost in the treatment of eyelash hypotrichosis
- Medical treatment of the hairline and temple points
- 5종의 한약 추출물이 함유된 헤어 에센스제품(HHRHG0202-80)이 in vitro 및 in vivo에서 육모 및 탈모 방지에 미치는 효과
- 004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?
- Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- High-throughput screening of small molecule Wnt/β-catenin activators for hair and nail growth
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- High-Throughput Screening for Discovering Small Molecules Capable of Increasing the Wnt/β-Catenin Signaling Pathway to Promote Hair and Nail Growth
- 43665 Participant Satisfaction Survey Outcomes in a Comparative At-Home Photobiomodulation Device Study for Hair Loss
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Pediatric Systemic Lupus Erythematosus